Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 3
2018 4
2019 3
2020 9
2021 13
2022 8
2023 5
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Results by year

Filters applied: . Clear all
Page 1
Fine-tuning PERK signaling for neuroprotection.
Halliday M, Hughes D, Mallucci GR. Halliday M, et al. J Neurochem. 2017 Sep;142(6):812-826. doi: 10.1111/jnc.14112. Epub 2017 Aug 8. J Neurochem. 2017. PMID: 28643372 Free PMC article. Review.
Resting-State Network Alterations Differ between Alzheimer's Disease Atrophy Subtypes.
Rauchmann BS, Ersoezlue E, Stoecklein S, Keeser D, Brosseron F, Buerger K, Dechent P, Dobisch L, Ertl-Wagner B, Fliessbach K, Haynes JD, Heneka MT, Incesoy EI, Janowitz D, Kilimann I, Laske C, Metzger CD, Munk MH, Peters O, Priller J, Ramirez A, Roeske S, Roy N, Scheffler K, Schneider A, Spottke A, Spruth EJ, Teipel S, Tscheuschler M, Vukovich R, Wagner M, Wiltfang J, Yakupov R, Duezel E, Jessen F, Perneczky R; DELCODE study group and the Alzheimer's Disease Neuroimaging Initiative (ADNI). Rauchmann BS, et al. Cereb Cortex. 2021 Oct 1;31(11):4901-4915. doi: 10.1093/cercor/bhab130. Cereb Cortex. 2021. PMID: 34080613 Free PMC article.
The Bio-Hermes Study: Biomarker database developed to investigate blood-based and digital biomarkers in community-based, diverse populations clinically screened for Alzheimer's disease.
Mohs RC, Beauregard D, Dwyer J, Gaudioso J, Bork J, MaGee-Rodgers T, Key MN, Kerwin DR, Hughes L, Cordell CB; Bio‐Hermes Collaborative Group. Mohs RC, et al. Alzheimers Dement. 2024 Apr;20(4):2752-2765. doi: 10.1002/alz.13722. Epub 2024 Feb 28. Alzheimers Dement. 2024. PMID: 38415908 Free PMC article.
Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer's continuum when only subtle changes in Aβ pathology are detected.
Suárez-Calvet M, Karikari TK, Ashton NJ, Lantero Rodríguez J, Milà-Alomà M, Gispert JD, Salvadó G, Minguillon C, Fauria K, Shekari M, Grau-Rivera O, Arenaza-Urquijo EM, Sala-Vila A, Sánchez-Benavides G, González-de-Echávarri JM, Kollmorgen G, Stoops E, Vanmechelen E, Zetterberg H, Blennow K, Molinuevo JL; ALFA Study. Suárez-Calvet M, et al. EMBO Mol Med. 2020 Dec 7;12(12):e12921. doi: 10.15252/emmm.202012921. Epub 2020 Nov 10. EMBO Mol Med. 2020. PMID: 33169916 Free PMC article.
Clinical meaningfulness of subtle cognitive decline on longitudinal testing in preclinical AD.
Papp KV, Buckley R, Mormino E, Maruff P, Villemagne VL, Masters CL, Johnson KA, Rentz DM, Sperling RA, Amariglio RE; Collaborators from the Harvard Aging Brain Study, the Alzheimer's Disease Neuroimaging Initiative and the Australian Imaging, Biomarker and Lifestyle Study of Aging. Papp KV, et al. Alzheimers Dement. 2020 Mar;16(3):552-560. doi: 10.1016/j.jalz.2019.09.074. Epub 2020 Jan 4. Alzheimers Dement. 2020. PMID: 31759879 Free PMC article.
45 results